DiaSorin LIAISON® SARS-CoV-2 IgM

GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000593430.1
Last updated: 2021-07-21
Annual Review past due read more
Test version history
- 593430.1, last updated: 2021-07-21

Clinical microbial testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for COVID-19
Offered by Mako Medical Laboratories

Interpretation

Not provided

Comments about the test interpretation (e.g. clinical implication of test results)

The analyzer automatically calculates SARS-CoV-2 IgM antibody concentrations expressed as an Index value and grades the results. Assay range: 0 – no limit. Negative result - A result below the 1.1 Index may indicate the absence or level of IgM antibodies to SARS-CoV-2 below the threshold. The test could score negative in patients during the incubation period and in the early stages of infection. Positive result - A result above or equal to the 1.1 Index generally indicates the presence of IgM antibodies to SARS-CoV-2 and generally indicates exposure to SARS-CoV-2. Test results are reported qualitatively as positive or negative. However, diagnosis of SARS-CoV-2 infection should not be established on the basis of a single test result, but should be determined in conjunction with clinical findings, patient history, and always in association with medical judgment.

Research

Is research allowed on the sample after clinical testing is complete?HelpAfter clinical testing is complete, does the laboratory perform any research testing using the submitted specimen? (Quality control is not considered as research for this question.): Not provided

Reviews

Clinical resources

Practice guidelines

NICE, 2024
UK NICE Guideline NG191, COVID-19 rapid guideline: managing COVID-19, 2024

Consumer resources

MedlinePlus

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.